{"id":"depiquick-birch-dpg103","safety":{"commonSideEffects":[{"rate":null,"effect":"Unknown"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Further research is needed to understand the exact mechanism of action of Depiquick Birch (DPG103).","oneSentence":"Depiquick Birch (DPG103) is a small molecule that targets the (unknown) mechanism.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:09:03.097Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Phase 3 for (unknown)"}]},"trialDetails":[{"nctId":"NCT01902992","phase":"PHASE3","title":"Efficacy and Safety of Intraseasonal Specific Immunotherapy With Depiquick® Birch","status":"COMPLETED","sponsor":"Novartis","startDate":"2012-03","conditions":"Allergic Rhinoconjunctivitis","enrollment":202}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Depiquick Birch (DPG103)","genericName":"Depiquick Birch (DPG103)","companyName":"Novartis","companyId":"novartis","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Depiquick Birch (DPG103) is a small molecule that targets the (unknown) mechanism. Used for Phase 3 for (unknown).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}